The Bowel Function Index for evaluating constipation in pain patients: definition of a reference range for a non-constipated population of pain patients.
about
Opioid-induced constipation: advances and clinical guidanceDevelopments in managing severe chronic pain: role of oxycodone-naloxone extended releaseConsensus Recommendations on Initiating Prescription Therapies for Opioid-Induced ConstipationEmerging therapies for patients with symptoms of opioid-induced bowel dysfunctionDevelopment of opioid-induced constipation: post hoc analysis of data from a 12-week prospective, open-label, blinded-endpoint streamlined study in low-back pain patients treated with prolonged-release WHO step III opioidsEfficacy and tolerability balance of oxycodone/naloxone and tapentadol in chronic low back pain with a neuropathic component: a blinded end point analysis of randomly selected routine data from 12-week prospective open-label observations.Opioid-induced constipation: pathophysiology, clinical consequences, and management.Oxycodone/Naloxone: role in chronic pain management, opioid-induced constipation, and abuse deterrenceLong-term evaluation of combined prolonged-release oxycodone and naloxone in patients with moderate-to-severe chronic pain: pooled analysis of extension phases of two Phase III trialsQuality of life and healthcare resource in patients receiving opioids for chronic pain: a review of the place of oxycodone/naloxoneLong-term safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate-to-severe chronic cancer pain.A randomized, double-blind, active-controlled, double-dummy, parallel-group study to determine the safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate/severe, chronic cancer pain.Quality of life under oxycodone/naloxone, oxycodone, or morphine treatment for chronic low back pain in routine clinical practice.Oxycodone/Naloxone prolonged-release: a review of its use in the management of chronic pain while counteracting opioid-induced constipation.Opioids in Gastroenterology: Treating Adverse Effects and Creating Therapeutic Benefits.Prolonged release oxycodone and naloxone treatment counteracts opioid-induced constipation in patients with severe pain compared to previous analgesic treatment.Prolonged-release oxycodone/naloxone in opioid-naïve patients - subgroup analysis of a prospective observational study.Prolonged-release oxycodone/naloxone in nonmalignant pain: single-center study in patients with constipation.Cancer pain therapy with a fixed combination of prolonged-release oxycodone/naloxone: results from a non-interventional study.The prevalence of constipation at admission and after 1 week of palliative care: a multi-center study.The efficacy of standard laxative use for the prevention and treatment of opioid induced constipation during oxycodone use: a small Dutch observational pilot study.Definition, diagnosis and treatment strategies for opioid-induced bowel dysfunction-Recommendations of the Nordic Working Group.Oral prolonged-release oxycodone/naloxone for managing pain and opioid-induced constipation: A review of the evidence.Opioid-induced constipation reversal in response to placebo in a patient with a history of IBS receiving methadone maintenance therapy.Prolonged-release oxycodone/naloxone in the treatment of neuropathic pain - results from a large observational study.A comparison of oxycodone prolonged-release vs. oxycodone + naloxone prolonged-release after laparoscopic hysterectomy.Reliability and validity of the Bowel Function Index for evaluating opioid-induced constipation: translation, cultural adaptation and validation of the Portuguese version (BFI-P).Re: opioid-induced constipation: challenges and therapeutic opportunities.Laxatives Do Not Improve Symptoms of Opioid-Induced Constipation: Results of a Patient Survey.Patient preference with respect to QoL and reduction in opioid-induced constipation (OIC) after treatment with prolonged-release (PR) oxycodone/naloxone compared with previous analgesic therapy [PREFER study].Efficacy and gastrointestinal tolerability of oral oxycodone/naloxone combination for chronic pain in outpatients with cancer: an observational study.Long-term efficacy and safety of oxycodone-naloxone prolonged-release formulation (up to 180/90 mg daily) - results of the open-label extension phase of a phase III multicenter, multiple-dose, randomized, controlled study.
P2860
Q26765571-143EE65D-821B-45A5-AF62-3D91711423B7Q26801140-366C23FC-35B9-437D-B2A8-0BA40EEB43A5Q26830397-E7D83B57-73D5-4809-BE50-CA1B05548300Q27010907-3F3AB31A-B45A-41DD-9933-F69B66E1E0A1Q30989361-4D6DC3C5-20CA-4EDE-B30A-DDC28966276BQ31144449-DBA07239-6386-4DD2-8CC9-90CE1D95B839Q33635040-D99086B4-1F2E-4889-99B5-3AA44094B453Q33938740-E535A09F-E6C9-4AC9-8A99-774A11D86189Q34693351-5F6F4D0F-68CD-49DF-93DC-F7A91DEC07BAQ34798408-CBCEDCE5-FD20-466F-8086-88931750EBB3Q35028902-2E098276-C14F-4E0A-8171-A9BED588A7A7Q35664979-A5FFFAD4-CCFF-4134-A182-906885821EDBQ36631510-31459648-4A5E-4F2E-81C5-38F2464F703FQ38181019-517BDEF8-BD08-48D5-93B6-6CB84AFA0396Q38772298-8FD80DDE-301C-45FE-8EBC-651CF802EBA3Q39151428-7697C55B-30F7-443C-ABCF-7B5622C4217DQ39195336-D2C97664-BFEE-4B00-85BF-DC029E648084Q39235593-0C41268D-413A-4F9E-9526-AAC48AEAFFC7Q39256745-CF4629CE-B126-4AAB-B104-B3D812966F8DQ40114587-77F96B28-38CF-4799-84FD-819C5D3055DBQ40238200-739D0FE9-8CA3-474A-8C3C-3FD6D2438120Q43062741-7A53678A-D1C7-45D8-83D3-76B82BA22E7BQ43075972-E42C92BC-2842-41B8-8698-5B5D84923E19Q43162368-985BEA48-8E36-4B26-B4BF-0563FC3CBAC8Q43338838-DD00B7FD-76AA-467A-83F3-7884BE51DE1FQ43353516-F0C408EA-521E-49B0-BBD3-E16861BDC728Q43357590-36CD8C86-9832-4B66-9B12-1FBF555A8947Q44331875-33ED180E-629C-404F-B35E-BB2C2C333B5DQ44344292-B255422D-951F-4324-B7E3-F13D6C0289A0Q44345000-72831617-61DE-4E89-AC96-E4DDE9E8C4D3Q46317999-C4707338-AA3C-45E9-B582-17AF397565C4Q47133351-78557699-9A82-446E-8A00-ED727A679DFE
P2860
The Bowel Function Index for evaluating constipation in pain patients: definition of a reference range for a non-constipated population of pain patients.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
The Bowel Function Index for e ...... d population of pain patients.
@en
The Bowel Function Index for e ...... d population of pain patients.
@nl
type
label
The Bowel Function Index for e ...... d population of pain patients.
@en
The Bowel Function Index for e ...... d population of pain patients.
@nl
prefLabel
The Bowel Function Index for e ...... d population of pain patients.
@en
The Bowel Function Index for e ...... d population of pain patients.
@nl
P2093
P2860
P1476
The Bowel Function Index for e ...... d population of pain patients.
@en
P2093
C Buschmann-Kramm
M A Ueberall
S Müller-Lissner
P2860
P356
10.1177/147323001103900106
P577
2011-01-01T00:00:00Z